Great West Life Assurance CO Agios Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 18,979 shares of AGIO stock, worth $587,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,979

Previous 20,073 5.45%

Holding current value

$587,020

Previous $892,000 30.16%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$32.86 - $61.64 $35,948 - $67,434	-1,094 Reduced 5.45%	18,979 $623,000
Q3 2024 Nov 13, 2024	SELL	$41.19 - $49.72 $193,675 - $233,783	-4,702 Reduced 18.98%	20,073 $892,000
Q2 2024 Aug 12, 2024	SELL	$27.55 - $48.83 $175,465 - $310,998	-6,369 Reduced 20.45%	24,775 $1.07 Million
Q1 2024 May 13, 2024	BUY	$21.32 - $34.81 $11,512 - $18,797	540 Added 1.76%	31,144 $911,000
Q4 2023 Feb 13, 2024	BUY	$19.97 - $24.53 $54,737 - $67,236	2,741 Added 9.84%	30,604 $677,000
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $11,400 - $13,188	-468 Reduced 1.65%	27,863 $689,000
Q2 2023 Aug 10, 2023	BUY	$21.38 - $29.19 $60,890 - $83,133	2,848 Added 11.18%	28,331 $807,000
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $11,957 - $17,011	550 Added 2.21%	25,483 $586,000
Q4 2022 Feb 10, 2023	BUY	$24.81 - $31.52 $339,276 - $431,036	13,675 Added 121.47%	24,933 $703,000
Q3 2022 Nov 01, 2022	BUY	$19.51 - $34.14 $219,643 - $384,348	11,258 New	11,258 $318,000
Q2 2022 Aug 09, 2022	BUY	$17.06 - $31.42 $2,576 - $4,744	151 Added 5.12%	3,101 $68,000
Q1 2022 May 12, 2022	BUY	$26.68 - $34.81 $3,761 - $4,908	141 Added 5.02%	2,950 $91,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $13,488 - $22,699	-456 Reduced 13.97%	2,809 $92,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $22,385 - $31,068	-534 Reduced 14.06%	3,265 $152,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $5,705 - $7,417	-129 Reduced 3.28%	3,799 $194,000
Q3 2020 Nov 17, 2020	BUY	$33.87 - $55.93 $133,041 - $219,693	3,928 New	3,928 $137,000
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $133,041 - $219,693	-3,928 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $118,154 - $198,717	3,928 New	3,928 $187,000
Q3 2019 Oct 25, 2019	SELL	$32.4 - $49.58 $223,333 - $341,754	-6,893 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$46.17 - $68.1 $36,566 - $53,935	-792 Reduced 10.31%	6,893 $0
Q1 2019 May 08, 2019	BUY	$45.92 - $67.67 $49,869 - $73,489	1,086 Added 16.46%	7,685 $517,000
Q4 2018 Feb 12, 2019	BUY	$42.73 - $76.53 $45,122 - $80,815	1,056 Added 19.05%	6,599 $294,000
Q3 2017 Nov 09, 2017	BUY	$54.89 - $67.12 $304,255 - $372,046	5,543	5,543 $359,000

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.7B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Agios Pharmaceuticals, Inc. Transaction History